Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 11:11 AM ET

Date/Time Source News Release
04/03/2025 04:05 PM EDT GlobeNewswire Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
03/31/2025 08:00 AM EDT GlobeNewswire Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
12/20/2024 08:00 AM EST GlobeNewswire Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
12/10/2024 04:05 PM EST GlobeNewswire Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
11/21/2024 08:00 AM EST GlobeNewswire Apollomics' Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
09/16/2024 08:00 AM EDT GlobeNewswire Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
09/04/2024 04:05 PM EDT GlobeNewswire Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/14/2024 06:00 AM EDT GlobeNewswire Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
08/13/2024 08:00 AM EDT GlobeNewswire Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
08/08/2024 04:05 PM EDT GlobeNewswire Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference
Page

Additional News

As of June 3, 2025 • 11:11 AM ET

Date/Time Source News Release
05/08/2025 04:18 AM EDT Stock Traders Daily (APLM) Pivots Trading Plans and Risk Controls
04/22/2025 09:40 PM EDT Stock Traders Daily When the Price of (APLM) Talks, People Listen
04/03/2025 04:13 PM EDT SeekingAlpha Apollomics GAAP EPS of -$52.80
03/31/2025 09:20 AM EDT SeekingAlpha Apollomics, LaunXP enter development, commercial agreement for Vebreltinib
03/31/2025 08:38 AM EDT 24/7 Market News Apollomics and LaunXP Team Up to Supercharge Vebreltinib in Asia's NSCLC Fight
03/27/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 27th, 2025
03/27/2025 05:30 AM EDT US Earnings Reports Expected earnings - Apollomics Inc.
03/06/2025 01:00 AM EST Stock Traders Daily (APLM) Trading Advice
01/22/2025 12:14 AM EST Stock Traders Daily (APLM) Long Term Investment Analysis
12/31/2024 10:00 PM EST Stock Traders Daily (APLM) Long Term Investment Analysis
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.